Liu Y, Axell O, van Leeuwen T, Konrat R, Kharaziha P, Larsson C
Int J Mol Sci. 2021; 22(12).
PMID: 34198491
PMC: 8231809.
DOI: 10.3390/ijms22126345.
Chen X, Yang D, Carey J, Karakas C, Albarracin C, Sahin A
Cancers (Basel). 2021; 13(7).
PMID: 33916118
PMC: 8036262.
DOI: 10.3390/cancers13071656.
Dong X, Lv S, Gu D, Zhang X, Ye Z
Front Oncol. 2021; 10:553628.
PMID: 33552947
PMC: 7858652.
DOI: 10.3389/fonc.2020.553628.
Alborelli I, Generali D, Jermann P, Cappelletti M, Ferrero G, Scaggiante B
Cell Death Dis. 2019; 10(7):534.
PMID: 31296838
PMC: 6624284.
DOI: 10.1038/s41419-019-1770-3.
Cui L, Zhou F, Chen C, Wang C
J Ovarian Res. 2019; 12(1):4.
PMID: 30651135
PMC: 6334460.
DOI: 10.1186/s13048-019-0479-3.
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
Mucaki E, Caminsky N, Perri A, Lu R, Laederach A, Halvorsen M
BMC Med Genomics. 2016; 9:19.
PMID: 27067391
PMC: 4828881.
DOI: 10.1186/s12920-016-0178-5.
Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis.
Goncalves M, Borja S, Cordeiro J, Saddi V, Ayres F, Vilanova-Costa C
Springerplus. 2015; 3:749.
PMID: 26034701
PMC: 4447735.
DOI: 10.1186/2193-1801-3-749.
A clinical and genetic analysis of multiple primary cancer referrals to genetics services.
Whitworth J, Hoffman J, Chapman C, Ong K, Lalloo F, Evans D
Eur J Hum Genet. 2014; 23(5):581-7.
PMID: 25248401
PMC: 4402633.
DOI: 10.1038/ejhg.2014.157.
Inherited and acquired alterations in development of breast cancer.
Rizzolo P, Silvestri V, Falchetti M, Ottini L
Appl Clin Genet. 2013; 4:145-58.
PMID: 23776375
PMC: 3681186.
DOI: 10.2147/TACG.S13226.
BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.
Buckley N, Mullan P
Stem Cell Rev Rep. 2012; 8(3):982-93.
PMID: 22426855
DOI: 10.1007/s12015-012-9354-y.
Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers.
Fang S, Krahe R, Bachinski L, Zhang B, Amos C, Strong L
Hum Genet. 2011; 130(6):789-94.
PMID: 21688173
PMC: 6497528.
DOI: 10.1007/s00439-011-1039-0.
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
Fang S, Krahe R, Lozano G, Han Y, Chen W, Post S
PLoS One. 2010; 5(5):e10813.
PMID: 20520810
PMC: 2877078.
DOI: 10.1371/journal.pone.0010813.
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Sinilnikova O, Antoniou A, Simard J, Healey S, Leone M, Sinnett D
Br J Cancer. 2009; 101(8):1456-60.
PMID: 19707196
PMC: 2768437.
DOI: 10.1038/sj.bjc.6605279.
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers.
Osorio A, Pollan M, Pita G, Schmutzler R, Versmold B, Engel C
Br J Cancer. 2008; 99(6):974-7.
PMID: 18781154
PMC: 2538750.
DOI: 10.1038/sj.bjc.6604624.
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.
Cavallone L, Arcand S, Maugard C, Ghadirian P, Mes-Masson A, Provencher D
BMC Cancer. 2008; 8:96.
PMID: 18402691
PMC: 2329651.
DOI: 10.1186/1471-2407-8-96.
Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R
BMC Cancer. 2008; 8:32.
PMID: 18230179
PMC: 2254432.
DOI: 10.1186/1471-2407-8-32.
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.
Bougeard G, Baert-Desurmont S, Tournier I, Vasseur S, Martin C, Brugieres L
J Med Genet. 2005; 43(6):531-3.
PMID: 16258005
PMC: 1904480.
DOI: 10.1136/jmg.2005.037952.
A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome.
Kim I, Kang H, Shin Y, Park H, Jang S, Han S
J Hum Genet. 2004; 49(11):591-595.
PMID: 15368100
DOI: 10.1007/s10038-004-0193-9.
